Combined FDG and NaF PET/CT study in patients (pts) with metastatic genitourinary tumors (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo+/-Ipi).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jeffrey Lin, Amir Mortazavi, Mark N. Stein, Sumanta K. Pal, Nicole N. Davarpanah, Rosa Maria Nadal, Deneise C Francis, Marilise Anne Berniger, Paul Monk, Jeffrey Kempf, Murray Becker, Levi Sokol, Yolanda McKinney, Michael V. Knopp, Chadwick Wright, Alex Jung, Peter L. Choyke, Esther Mena, Liza Lindenberg, Andrea B. Apolo
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Rutgers Cancer Institute, City Of Hope National Medical Center, The Ohio State University, Rutgers, The State University of New Jersey
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889560736